Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.92M Buy
25,263
+6,439
+34% +$1.33M 0.17% 104
2026
Q1
$4.23M Buy
18,824
+806
+4% +$201K 0.16% 103
2025
Q4
$4.34M Buy
18,018
+406
+2% +$104K 0.17% 102
2025
Q3
$4.82M Buy
17,612
+17,606
+293,433% +$4.81M 0.2% 96
2025
Q2
$1.55K Buy
6
+4
+200% +$954 ﹤0.01% 1150
2025
Q1
$448 Buy
+2
New +$467 ﹤0.01% 1313

Other funds holding RMD

Bogart Wealth LLC's RMD Position: Q2 2026 in Review

Bogart Wealth LLC increased its ResMed (RMD) stake by 34% in Q2 2026, buying an estimated $1.33M and bringing the position to 25,263 shares worth $4.92M. The position accounts for 0.17% of the portfolio, ranked #104.

Bogart Wealth LLC first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Bogart Wealth LLC held 25,263 shares of ResMed worth $4.92M as of Q2 2026.
  • Bogart Wealth LLC bought 6,439 ResMed shares in Q2 2026, an estimated $1.33M.
  • ResMed made up 0.17% of Bogart Wealth LLC's portfolio in Q2 2026, its #104 holding.
  • Bogart Wealth LLC first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.